A panel of monoclonal antibodies with specificity for a wound isolate of Proteus mirabilis was established. Of nine antibodies studied in detail, three were broadly reactive with various Proteus isolates, while six reacted in a serotype-specific fashion with the strain used for immunization. Five of the six serotype-specific antibodies were reactive with lipopolysaccharide. The sixth serotype-specific antibody, 4-F (immunoglobulin Gl [IgGl]), was potently protective in a burn wound sepsis model and recognized a protein antigen. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot (immunoblot) analysis were used to determine that 4-F was reactive with flagellar protein. Approximately 1.3 ,Ig of the antibody was sufficient to provide protection against 8 50% lethal doses of the wound isolate, and approximately 26 ,ug provided full protection against challenge with 333 50% lethal doses. In vitro test results indicated that 4-F inhibited the motility of the wound isolate, and in vivo testing showed that it inhibited dissemination of the inoculum from the burn site to the liver and spleen. Whereas the antibody was highly effective in preventing the death of mice subsequent to challenge at a burn site, no protection was seen following an intraperitoneal challenge. These results may therefore indicate that the protection observed in the burn model is solely a reflection of the capacity of 4-F to neutralize bacterial motility.
Monoclonal antibodies (MAbs) with specificities against a variety of bacterial structures have provided protection in experimental gram-negative infection models. Such structures have included lipopolysaccharide (LPS) side chains (18, 33) , conserved core LPS regions including lipid A (3, 35) , a polymorphic core LPS epitope (6, 10) , capsular polysaccharides (7, 12) , porin outer membrane protein (14, 27) , and fimbrial adhesins (1, 28) . MAbs with specificities for serotypic LPS determinants, including human antibodies (26, 30) , have generally been most effective at providing protection. It is therefore widely believed that a cocktail of MAbs which recognize a variety of LPS 0-antigen side chains could provide effective prophylaxis and therapy against infection. However, the extreme polymorphic nature of such side chains requires that a cocktail with a broad spectrum of efficacy would need to be composed of several antibodies.
To avoid the necessity of a complex cocktail, several groups of investigators have searched for MAbs with broadspectrum, anti-gram-negative activities. Examples of protective antibodies described to date with such activities include anti-Pseudomonas aeruiginosa porin (14) and anti-Escherichia coli J5 core LPS (10, 35) . However, these antibodies have generally been weakly protective with respect to MAbs which recognize LPS side chains (10, 25, 27 ).
An alternative approach to opsonizing or endotoxin-neutralizing antibodies is the isolation of antibodies which neutralize virulence factors related to invasiveness. Studies with MAbs against fimbrial adhesins (pili) have shown that bacterial colonization is blocked by the prophylactic use of antibody, which inhibits the interaction of the adhesin with its complementary host cell receptor (1, 28) . Similarly, the association of microorganism motility with virulence for Pseudomonas aeruiginosa (21, 23) , Vibrio cholerae (13) , and Proteus mirabilis (20) has been established. The virulence has been associated with mutants which lost their flagellar function (20, 21, 23) . Immunization with flagellar antigen from Pseudomonas aeruginosa has provided protection to vaccinated burned mice (16, 17) , and serological studies have indicated that there is a restricted polymorphism associated with serotypic flagellar determinants (2, 16) . These results indicate, at least for Pseudomonas aeruginosa, that relatively simple MAb cocktails with specificities for flagellar antigens may provide effective, broad-spectrum prophylactic activities.
Proteus mirabilis is a frequent cause of nosocomial infections and is most commonly isolated from the urinary tract and less frequently from wounds, burns, eyes, and other sites. It possesses numerous peritrichous flagella and is highly motile in liquid and soft agar media. We Immunization of mice. Two female BALB/c mice received a primary intraperitoneal immunization at 7 to 9 weeks of age with 0.1 ml of a suspension of live Proteus mirabilis 4550 cells. Secondary intraperitoneal and tertiary intravenous immunizations were done with 0.1 ml of a suspension of P. mirabilis 4550 cells at days 21 and 42 following the primary immunizations, respectively. Secondary and tertiary immunizations were made with cell suspensions yielding an optical density at 660 nm of 0.1, while primary immunizations were made with a 1:10 dilution of such a suspension. All suspensions and dilutions were made in phosphate-buffered saline (PBS). Spleens were harvested for fusion 3 days following tertiary immunization.
Cell fusion. For the production of the monoclonal antibodies, M5 cells, derived from a horse serum-adapted line of SP2/O-Agl4 (29) , were grown in Dulbecco modified Eagle medium (GIBCO Laboratories, Grand Island, N.Y.) supplemented with 10% immunoglobulin-free horse serum (VSP horse serum; Biocell Laboratories, Carson, Calif.), 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), 100 IU of penicillin per ml, 100 ,ug of streptomycin per ml, and modified Eagle medium with nonessential amino acids. The fusion and culturing techniques were basically those of Kohler and Milstein (19) , with minor modifications (15) . Fusion PM-5 was initiated with 34% polyethylene glycol (molecular weight, 1,500; Aldrich Chemical Co., Inc., Milwaukee, Wis.) at a ratio of three immunized splenocytes to one myeloma cell, while fusion PM-6 was initiated under similar conditions except that the polyethylene glycol solution contained 5% dimethyl sulfoxide. The fusion mixture was distributed into 96-well plates at approximately 3 x 105 spleen cells per 0.2 ml of hypoxanthine aminopterin-thymidine medium per well. Positive culture wells were selected on the basis of enzyme-linked immunosorbent assay (ELISA) reactivity with P. mirabilis 4550 lysates, and clonal hybridoma populations producing the antibodies of interest were isolated by limiting dilution culture and ELISA. After clones were established, they were expanded by growth in supplemented Dulbecco modified Eagle medium and by growth in ascitic fluid in BALB/c mice which were primed with pristane. Clarified tissue culture supernatant, ascitic fluids, or both were used as the source of antibodies for all of the assays described below. Control ascitic fluid was derived from the injection of the M5 (SP2/O-Agl4) myeloma parent. Antibody isotypes were determined by using culture supernatants and a commercial enzyme immunoassay kit (Zymed Laboratories, Inc., South San Francisco, Calif.).
ELISA. Antibodies were detected by using antigencoated, round-bottom, polystyrene 96-well microtiter plates (Immulon 2; Dynatech Laboratories, Inc., Alexandria, Va.).
Wells were coated with 50 ,ul of one of three bacterial antigen preparations: lysate, whole cell, or LPS. Bacterial lysates were prepared by sonication and diluted to an optical density at 280 nm of 0.025 in 50 mM sodium carbonate-bicarbonate buffer (pH 9.6). Coated plates were incubated for 3 h at 37°C before wells were washed with PBS and filled with 1% bovine serum albumin. The plates were then incubated for 1 h at 37°C prior to storage at -20°C. LPS-coated plates were prepared by adding 50 ,lI of a 10-Rg/ml solution in carbonate buffer to each well. The LPS preparations were obtained by hot phenol extraction (36) . LPS plates were incubated, blocked with bovine serum albumin, and stored as described above. Formalin-killed bacteria were suspended in PBS to an optical density at 660 nm of 0.123 for preparations of whole-cell plates. Whole-cell suspension (50 p.1) was added to wells before centrifugation of the plates at approximately 550 x g for 20 min. The PBS was then removed from the wells, and the plates were incubated with 1% bovine serum albumin for 1 h at 37°C before they were stored at -20°C. For two experiments, plates were also prepared with heattreated or pronase-digested, Formalin-killed whole cells. Heat-treated cells were prepared by autoclaving them for 0.5 h at 121 to 122°C and 15 lb/in2. Pronase treatment was with 0.1 mg of enzyme per ml in PBS overnight at 37°C.
Prior to use, the plates were thawed by incubating them for 1 h at 37°C. Wells were washed once with PBS prior to the addition of diluted tissue culture supernatants. All assays were run in duplicate with serial fivefold dilutions of supernatants in PBS containing 0.05% Tween 20 (PBS-T20). After the addition of the diluted supernatants, the plates were incubated at room temperature for 30 min and subsequently washed three times with PBS-T20. The assays were completed with reagents from a commercial kit (avidin-biotinylated horseradish peroxidase complex reagent; mouse immunoglobulin G [IgG] heavy and light chains; Vectastain;
Vector Laboratories, Burlingame, Calif.). Biotinylated antimouse IgG (50 p.l) diluted in PBS-T20 was added to each well, and the plates were incubated at room temperature for 15 min before they were washed three times with PBS-T20. Avidin-biotinylated horseradish peroxidase complex reagent (50 ,ul) diluted in PBS-T20 was then added to each well, and the plates were incubated for 15 min at room temperature before they were washed five times with PBS-T20. Substrate solution (100 pu) consisting of equal parts of 0.03% hydrogen peroxide and 0. 8 .75% glycerol) for 4 and 10 min, respectively; and LPS or whole-cell extracts were applied to the gels at 6 and 10 p.1 per lane, respectively. Prestained protein molecular weight standards (molecular weights, 95,500 to 12,000; midrange kit; Diversified Biotech, Newton Centre, Mass.) were run (see Fig. 1, lanes 3, 6, and 9 ). Duplicate gels were run; one was used for electroblotting, and the other was silver stained. SDS-polyacrylamide gel electrophoresis was carried out with a 4.5S% acrylamide stacking gel and a 10 to 15% gradient resolving gel with constant voltage (stacking gel, 90 V; resolving gel, 110 V) for 90 min. Transfer onto 0.2-p.m-pore-size nitrocellulose filters (Sartorius, Hayward, Calif.) was achieved by electroblotting the gels overnight at a constant current of 100 mA by using a Trans-Blot cell (Bio-Rad Laboratories, Richmond, Calif.). The membrane was then cut at lanes 3, 6, and 9 (see Fig. 1 ). Excess nitrocellulose binding sites were blocked by shaking the filters for 1 h in 5% nonfat dry milk-0.01% antifoam A emulsion (Sigma Chemical Co., St. Louis, Mo.) in PBS. The membrane fragments were then incubated in antibody solutions for 1 h. All ascitic fluid samples were diluted 1:100 in PBS containing 1% gelatin (Bacto Certified; Difco Labora-VOL. 57, 1989 on June 22, 2017 by guest http://iai.asm.org/ Downloaded from tories, Detroit, Mich.). Protein A-purified antibody PlC9 (33) was diluted to 10 p.g/ml in the same buffer. The blots were washed three times in PBS-T20 and then immersed for 1 h in a solution containing horseradish peroxidase-conjugated rabbit anti-mouse IgG and IgM (immunoaffinity purified, heavy and light chain specific; Jackson ImmunoResearch Laboratories, Inc., West Grove, Pa.) diluted 1:500 in PBS-T20. After the blots were washed four times in PBS-T20, they were immersed in substrate solution made by mixing 25 ml of PBS, 5 ml of 3 mg of 4-chloro-1-naphthol per ml in methanol, and 10 ,ul of 30% H202. After color development, the membranes were washed in deionized water and air dried at room temperature.
Determination of ascitic fluid IgGI content. The approximate concentration of IgGl in ascitic fluid derived from hybridoma 4-F was determined to be 16.5 mg/ml by using a radial immunodiffusion kit (The Binding Site, Inc., San Diego, Calif.).
Direct examination. One drop of fresh P. mirabilis 4550 liquid culture grown at 37°C was mixed on the surface of a slide with one drop of murine ascitic fluid containing the 4-F MAb that was reactive with P. mirabilis 4550. As a control, nonimmune ascitic fluid was mixed with P. mirabilis 4550 culture. The mixture was covered with a cover slip and examined by light microscopy.
Inhibition of motility in soft agar. To 50 ml of molten motility medium (BBL Microbiology Systems, Cockeysville, Md.) was added 0.5 ml of 4-F ascitic fluid, control ascitic fluid, or saline. The agar was poured into culture plates and allowed to harden. In the center of the agar was stabbed a loopful of P. mirabilis 4550. The plates were incubated at 37°C and observed for characteristic P. mirabilis swarming.
Inoculum preparation. P. mirabilis 4550, a clinical strain isolated from a leg wound, was maintained in brain heart infusion broth at -70°C. On the day preceding an animal study, a vial of culture was thawed and subcultured overnight on brain heart infusion agar. On the day of animal challenge, the overnight culture was subcultured onto fresh brain heart infusion agar slants. After 4 to 5 h of incubation at 37°C, log-phase cells were harvested by washing the slants with isotonic saline. Cells were washed once and suspended in saline. The cell concentration in the inoculum was determined by correlating the absorption of the suspension at 660 nm with predetermined plate counts. After challenge of the mice, the exact number of CFU in the inoculum was determined by plate counts on brain heart infusion agar.
Animal challenge. The dorsal fur of female Swiss-Webster mice (weight, 24 to 26 g) was clipped from head to tail. Saline dilutions of the 4-F ascitic fluid were injected intraperitoneally in a 0.1-ml volume. Two to three hours later, mice were anesthetized, to minimize discomfort, with an intraperitoneal injection of sodium pentobarbital (60 to 80 mg/kg of body weight). A silica cloth with an oval hole (2 by 4 cm, 5.8 cm2) was placed over the back, and mice were given a 10% body surface area full-thickness burn for 5 s with a gas burner (Fischer) (5). An inoculum in 0.5 ml of cold saline solution was then injected into the subcutaneous tissue of the burn site. Mice were observed for 15 days following challenge. In one experiment, the skin of the burn site, livers, and spleens of mice were removed at 18 h after challenge, homogenized, serially diluted in saline, and cultured on MacConkey agar to enumerate the P. mirabilis 4550 CFU in tissues. In one study, 0.5 ml of P. mirabilis 4550 isolates suspended in 7% porcine gastric mucin (type II; Sigma) was injected by the intraperitoneal route (35) 3 h after (22) . The antibody reacted with the major protein species, which could be detected on a companion silver-stained gel, and this protein corresponded in molecular weight (approximately 40,000) to that described by Driver and Lambert (8) for Proteius flagellar protein.
To further define the specificity of this reaction and to ensure that the interaction of 4-F with flagellar protein was not caused by a nonspecific protein-protein interaction, antibodies 4-F, 2-F, and 2-C were blotted against electrophoretically separated whole-cell extracts from Proteuls mirabilis 4550 and Pseiadomnonas (ierigillosa Fisher immunotype 1 (Fig. 1) . Antibody P1C9 (33) , which is reactive with the International Antigen Typing System (IATS) serotype 6 corresponding to Fisher immunotype 1, was included as a positive control. While it showed only diffuse reactivity with high-molecular-weight components from the Protelus extract, antibody P1C9 reacted strongly with the characteristic LPS ladder from Pseludomnonas preparations (both wholecell extract and purified LPS). Antibodies 4-F, 2-F, and 2-C were nonreactive with the Pseuidomonas extract; but they showed specific reactivities with components from the Proteias extract. Antibody 2-C reacted with a broad, lowmolecular-weight (approximately 12,000 to 18,000) band, ination of P. mirabilis from the burn wound and the subsequent death of mice, no protection was seen against an intraperitoneal challenge (Table 5) .
DISCUSSION
For serious infection to occur, a pathogen must disseminate from the site of initial colonization. This is accomplished by elaboration of virulence factors which compromise host defense mechanisms. Several such virulence factors have been described for P. mirabilis. In urine, the enzyme urease degrades urea with the generation of ammonia, which may damage the urinary tract epithelium and thus promote a serious kidney infection (3). When inoculated into rat bladders, heavily piliated strains of P. mirabilis cause ascending pyelonephritis more frequently than do lightly piliated strains, presumably by facilitating a greater adhesion of cells to the renal pelvis (32) . There is considerable evidence to suggest that flagella are also a virulence factor of P. mirabilis. In rats immunized with flagella, immobilizing antibody in the urine prevents homologous, motile P. mirabilis from ascending the ureter to the kidney (24) . Also, nonmotile mutants of P. mirabilis are considerably less virulent in burned rats than motile parent strains are (20) .
This study indicates that MAb 4-F inhibits the motility of P. mirabilis and is highly protective in experimental burn wound sepsis. It is noteworthy that treatment with 4-F markedly inhibited proliferation of P. mirabilis 4550 in the tissue of the burn site to the extent that there were 104-to 106-fold fewer CFU in the skin of 4-F-treated mice than in control mice (Table 4) . In this regard, it is interesting that MAb 4-F was not protective when bacterial challenge was administered by the intraperitoneal route. It can be argued that mucin compromised murine peritoneal phagocyte function. However, this model has been used by Teng et al. (35) to demonstrate the protective activity of MAb to E. coli J5 LPS against several gram-negative pathogens. The antibody is of the IgGl isotype and, therefore, most likely does not function through complement-enhanced opsonization (11) or through interaction with high-affinity Fc receptors on the surface of effector cells (9) . The marked protection observed after inoculation at the burn site may therefore solely reflect the capacity of the antibody for the neutralization of motility. Alternatively, MAb 4-F may function as an opsonin through low-affinity Fc receptors, and the intraperitoneal model may not allow detection of this activity.
Recent reports have emphasized the need to reevaluate protection studies by using passively administered MAbs in animal models. Antibodies that were apparently protective after purification were contaminated with small quantities of endotoxin, and the protection was actually mediated by an LPS-induced mechanism (4, 37) . Since all of our MAb reagents were prepared as culture supernatants, ascitic fluid, or both, were handled asceptically, and were not subjected to potential contamination through purification, it is unlikely that the protection observed with 4-F was caused by LPS contamination. Furthermore, batches of nonprotective MAbs and control ascitic fluid were prepared with the same materials that were used for the protective 4-F preparations.
Although MAbs 4-F and 2-F both appeared to recognize epitopes associated with flagellar protein, preliminary experiments failed to show protection when antibody 2-F was used. Both antibodies were IgGI isotypes, and the difference in apparent protective capacity is not, therefore, derived from a difference in effector function associated with the isotype. The epitope defined by antibody 2-F does not appear to be highly polymorphic among Proteus 
